TSHA Stock Earnings: Taysha Gene Therapies Beats EPS, Beats Revenue for Q4 2023

Taysha Gene Therapies (NASDAQ: ) just reported results for the fourth quarter of 2023. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue,…#tradesmith
Source: Reuters: Health - Category: Consumer Health News Source Type: news